The immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is complex and variable by disease severity, and the immunopathology of severe COVID-19 has been well studied since the inception of the pandemic. A broad spectrum of abnormal and dysregulated immune responses have been observed amongst the moderately to critically ill. However, it is